When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
| Health Care Providers & Services Industry | Healthcare Sector | J. David Joyner CEO | XDUS Exchange | US1266501006 ISIN |
| US Country | 300,000 Employees | 23 Jul 2026 Last Dividend | 7 Jun 2005 Last Split | 17 Dec 1984 IPO Date |
CVS Health Corporation is a leading provider of health solutions in the United States, with a comprehensive portfolio that spans across Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness sectors. As an integral part of the healthcare ecosystem, CVS Health offers a broad range of products and services designed to meet the needs of various stakeholders, including employers, individuals, health plans, and governmental entities. Initially named CVS Caremark Corporation, the company underwent a rebranding to CVS Health Corporation in September 2014, emphasizing its broadened focus on health and wellness. Founded in 1996 and headquartered in Woonsocket, Rhode Island, CVS Health has grown into a cornerstone of the American healthcare industry, continually evolving to address the complex challenges of modern healthcare.
CVS Health Corporation offers a diversified array of healthcare products and services, categorized into three main segments: